[ Price : $8.95]
FDA grants orphan drug designation to Versartis for its long-acting form of recombinant human growth hormone.[ Price : $8.95]
Mylan signs an agreement with Pfizer for worldwide rights to develop a novel long-acting muscarinic antagonist compound for variou...[ Price : $8.95]
Scientists from two U.S. government national laboratories recommend using certain X-rays to speed investigations aimed at understa...[ Price : $8.95]
Public Citizen writes FDA asking it to stop making misleading statements about pharmacy compounding that could lead health care pr...[ Price : $8.95]
Ikaria files a third supplement to its petition asking that FDA revoke its orphan drug designation for GeNOs nitric oxide product....[ Price : $8.95]
The HHS Inspector General says FDA must continue on its three-year program to implement provisions of the 2012 FDA Safety and Inno...[ Price : $8.95]
GlaxoSmithKline announces significant changes to marketing practices, including not based sale representative compensation on the ...[ Price : $8.95]
FDA orders a new warning on certain attention deficit hyperactivity disorder drugs because in rare instances they cause prolonged ...